Efektivitas Hemodialisa Berdasarkan Parameter Hemoglobin, Eritrosit, Dan Hematokrit Pada Penderita Gagal Ginjal Kronik
Abstract
Various diseases that cause kidney dysfunction that cause problems in the body such as the accumulation of metabolic waste, decreased hormone production that can cause chronic kidney failure. Hemodialysis is used to replace damaged kidney function, in patients with kidney failure who undergo hemodialysis will experience anemia (80-95%). This study aims to determine the effectiveness of hemodialysis in patients with chronic renal failure. This study uses an observational analytic method using primary data with a total sample of 30 respondents. This research was conducted in May at the Asy-Syifa Regional Hospital in West Sumbawa. Statistic test uses Wilcoxon because it is found that the data is not normally distributed, that is <0.05. The results of this study indicate that there is an increase in hemoglobin levels, hematocrit values, and the number of erythrocytes after hemodialysis.
Keywords
Full Text:
PDFReferences
Adhiatma, A. T., Wahab, Z., Fajar, I., & Widyantara, E. (2014). Analisis Faktor-Faktor yang Berhubungan dengan Kejadian Gagal Ginjal Kronik Pada Pasien Hemodialisis Di RSUD Tugurejo Semarang Analysis of Factors Related to Chronic Kidney Disease in Hemodialysis Patients of RSUD Tugurejo Semarang. Fakultas Kedokteran Universitas Muhammadiyah Semarang, 1–10.
Analis, A., Delima, K., & Gresik, H. (2015). PERBANDINGAN KADAR HEMOGLOBIN SEBELUM DAN SESUDAH HEMODIALISA PADA PASIEN GAGAL GINJAL KRONIK DI RSU Dr. SAIFUL ANWAR, MALANG Rosidah *) , Hanif Sumitro Utomo. Jurnal Sains, 5(10).
Aru W Sudoyo. (2009). Ajar Ilmu Penyakit Dalam (Jilid 2. E). Interna Publishing;
Evitasari Dwitarini, N., Herawati, S., & Subawa, A. (2017). Perbedaan Kadar Hemoglobin Sebelum Dan Sesudah Hemodialisis Pada Pasien Penyakit Ginjal Kronis Di Rumah Sakit Umum Pusat Sanglah Denpasar Bali. E-Jurnal Medika Udayana, 6(4).
Ii, B. A. B. (2003). Hubungan Perilaku Pasien..., Akbar Dhika Tri Purwono, Fakultas Ilmu Kesehatan UMP, 2017. 10–20.
Ilmiah, K. T., & Pratiwi, L. I. A. D. W. I. (2018). PERBEDAAN KADAR HEMOGLOBIN PADA PENDERITA GAGAL GINJAL KRONIS SEBELUM DAN SESUDAH HEMODIALISA (Studi di RSUD Jombang ). 2018.
Kandarini, Y. (2017). Penatalaksanaan anemia pada penyakit ginjal kronik. 13–14.
Khanmohamadi, S. A. (2014). In light of another’s word: European ethnography in the middle ages. In Light of Another’s Word: European Ethnography in the Middle Ages, 2, 1–211. https://doi.org/10.1080/13507486.2015.1047603
Notoatmodjo, S. (n.d.). Metodologi Penelitian Kesehatan.
Oliver, J. (2019). 済無No Title No Title. Hilos Tensados, 1, 1–476. https://doi.org/10.1017/CBO9781107415324.004
Pendidikan, P., Spesialis, D., Klinik, P., Sakit, R., & Sadikin, H. (2016). Pemeriksaan Fungsi Ginjal. 43(2), 148–154.
Predictors of survival among end stage renal failure patients undergoing dialysis treatment in Pahang from 2000 to 2004. (2009). Malaysian Journal of Community Health, 15(1), 75–84.
Ri, K. K. (2018). Situasi PTM di Indonesia. (November), 1–18.
Suzanne C. Smeltzer, B. G. B. (2013). Buku Ajar Keperawatan Medical Bedah Volume 3 - Brunner dan Suddarth.
Ulya, I. (2007). Perbedaan Kadar Hb Pra dan Post Hemodialisa pada Penderita Gagal Ginjal Kronis di RS PKU Muhammadiyah Yogyakarta The Difference of Hb Levels Pre and Post Hemodialysis in Chronic Renal Failure Patients at PKU Muhammadiyah Hospital Yogyakarta. 7(1), 29–33.
Utami, P. R., & Fuad, K. (2018). GAMBARAN KADAR HEMOGLOBIN PADA PENDERITA DIABETES. 5.
Widyastuti, R., Butar-butar, W., & Bebasari, E. (2014). Korelasi Lama Menjalani Hemodialisis Dengan Indeks Masa Tubuh Pasien Gagal Ginjal Kronik DI RSUD Arifin Achamad Povinsi Riau pada Bulan Mei Tahun 2014. Jom FK, 1(2), 1–12.
Wiliyanarti, P. F., Komunitas, D., & Majapahit, S. (2019). LIFE EXPERIENCE OF CHRONIC KIDNEY DISEASES UNDERGOING HEMODIALYSIS. 4(1).
DOI: https://doi.org/10.32807/jambs.v7i2.198
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Jurnal Analis Medika Biosains (JAMBS)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.